Company news, press releases, and more. Follow this page for new exciting updates and more news on what is happening at CELLINK.
Following an agreement in August of this year, CELLINK and the Indian Institute of Science (IISc) have opened the doors to the first 3D bioprinting
NeuroBeta is a project where several partners, including Professor Kozlovas group at Uppsala University, are collaborating to further investigate the effect of microgravity on beta
Göteborgs Companipris is an annual award handed out by Göteborg & Co to innovative companies based in the Gothenburg region of Sweden. After being awarded
Podcast 3D Bioprinting – Accelerating Drug Discovery Join us for an interesting discussion on how 3D bioprinting contributes to accelerating drug discovery and tissue engineering.
The Centre of Excellence (CoE) will be focused on advancing research across heart, bone, cartilage and cancer research through the use of 3D bioprinting. CELLINK,
As part of the research call Prospekt 21, financed in part by a grant provided by KK Stiftelse, the group will work to develop diagnostic
The judges at SLAS Europe 2022, held in Dublin on May 24-27, granted the New Product Award to the BIO CELLX biodispenser. We are thrilled
Adding Allegro 3D to the portfolio enables BICO Bioprinting to strengthen its position as the global leader in providing 3D bioprinters. BICO has a robust
The leading 3D bioprinting company, CELLINK, has entered the most important distribution partnership in Latin America in 2022 with widely known supplier, CTR Scientific, to
During the collaboration CELLINK will provide expertise on biofabrication and bioink development with Zoan BioMed contributing their in-depth knowledge of coral growth characteristics and its
Avijit Minocha
Head of Marketing
akm@bico.com
Send us an email by filling in the contact form here.
U.S.: +1 (833) 235-5465
EU: +46 31-12 87 00
India: +91 (0) 98808 58741
Japan: +81 (75)746-3032
Singapore: +65 8750 2284
